Skip NavigationSkip to Content

Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn

  1. Author:
    Tilbrook, P. A.
    Palmer, G. A.
    Bittorf, T.
    McCarthy, D. J.
    Wright, M. J.
    Sarna, M. K.
    Linnekin, D.
    Cull, V. S.
    Williams, J. H.
    Ingley, E.
    Schneider-Mergener, J.
    Krystal, G.
    Klinken, S. P.
  2. Author Address

    Western Australian Inst Med Res, 6th Floor, MRF Bldg, Rear, 50 Murray St, Perth, WA 6000, Australia. Royal Perth Hosp, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia. Univ Western Australia, Dept Biochem, Perth, WA 6000, Australia. British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada. Humboldt Univ, Charite, Inst Med Immunol, Berlin, Germany. NCI, Frederick Canc Res & Dev Ctr, Basic Res Lab, Div Basic Sci, Frederick, MD 21702 USA. Univ Rostock, Inst Med Biochem, Rostock, Germany. Klinken SP Western Australian Inst Med Res, 6th Floor, MRF Bldg, Rear, 50 Murray St, Perth, WA 6000, Australia.
    1. Year: 2001
  1. Journal: Cancer Research
    1. 61
    2. 6
    3. Pages: 2453-2458
  2. Type of Article: Article
  1. Abstract:

    This study examined the impact of the tyrosine kinase Lyn on erythropoietin-induced intracellular signaling in erythroid cells. In J2E erythroleukemic cells, Lyn coimmunoprecipitated with numerous proteins, including SHP-1, SHP-2, ras-GTPase- activating protein, signal transducers and activators of transcription (STAT) 5a, STAT5b, and mitogen-activated protein kinase; however, introduction of a dominant-negative Lyn (Y397F Lyn) inhibited the interaction of Lyn with all of these molecules except SHP-1. Cells containing the dominant-negative Lyn displayed altered intracellular phosphorylation patterns, including mitogen-activated protein kinase, but not erythropoietin receptor, Janus-activated kinase (JAK) 2, or STAT5. As a consequence, erythropoietin-initiated differentiation and basal proliferation were severely impaired. Y397F Lyn reduced the protein levels of erythroid transcription factors erythroid Kruppel-like factor and GATA-1 up to 90%, which accounts for the inability of J2E cells expressing Y397F Lyn to synthesize hemoglobin. Although Lyn was shown to bind several sites on the cytoplasmic domain of the erythropoietin receptor, it was not activated when a receptor mutated at the JAK2 binding site was ectopically expressed in J2E cells, indicating that JAK2 is the primary kinase in erythropoietin signaling and that Lyn is a secondary kinase. In normal erythroid progenitors, erythropoietin enhanced phosphorylation of Lyn; moreover, exogenous Lyn increased colony forming unit- erythroid, but not burst forming unit-erythroid, colonies from normal progenitors, demonstrating a stage-specific effect of the kinase. Significantly, altering Lyn activity in J2E cells had a profound effect on the development of erythroleukemias in vivo: the mortality rate was markedly reduced and latent period extended when either wild-type Lyn or Y397F Lyn was introduced into these cells. Taken together, these data show that Lyn plays an important role in intracellular signaling in nontransformed and leukemic erythroid cells.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel